EU reveals proposals on pharma in TTIP talks
This article was originally published in Scrip
Executive Summary
The European Commission has released a number of texts laying out the EU's proposals on specific issues, including pharmaceutical and medical device regulation, that are under discussion with the US government as part of the negotiations on the Transatlantic Trade and Investment Partnership (TTIP). The commission says this is the first time it has made such proposals public during bilateral trade talks, and that this "reflects its commitment to greater transparency in the negotiations".